Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma: A cross-sectional case-control study from Chinese patients with HBV infection

Hepatobiliary and Pancreatic Diseases International

Volumn 12, Issue 4, 2013, Pages 385-393

  Gao, Chun ^a   Fang, Long ^a   Zhao, Hong Chuan ^a   Li, Jing Tao ^a   Yao, Shu Kun ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Chronic hepatitis B; Cirrhosis; Diabetes mellitus; Hepatocellular carcinoma

Indexed keywords

ALBUMIN; BILIRUBIN; HEMOGLOBIN;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE CONTROL STUDY; CHINESE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DECOMPENSATED LIVER CIRRHOSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEPATITIS B; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SMOKING; THROMBOCYTE COUNT;

ADULT; AGED; ALANINE TRANSAMINASE; ALPHA-FETOPROTEINS; BILIRUBIN; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEMOGLOBINS; HEPATITIS B, CHRONIC; HUMANS; HYPERTENSION; LEUKOCYTE COUNT; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OBESITY; PORTAL VEIN; RISK FACTORS; SERUM ALBUMIN;

EID: 84886391056     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(13)60060-0     Document Type: Article

References (33)

1. Yuen MF, Hou JL, Chutaputti A; Asia Pacifc Working Party on Prevention of Hepatocellular Carcinoma. Hepatocellular carcinoma in the Asia pacifc region. J Gastroenterol Hepatol 2009;24:346-353.
2. Gao C, Yao SK. Diabetes mellitus: a true independent risk factor for hepatocellular carcinoma? Hepatobiliary Pancreat Dis Int 2009;8:465-473.
3. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003;139:817-823.
4. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005;54:533-539.
5. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460-468.
6. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008;371: 838-851.
7. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002;36:1206-1213.
8. Yuan JM, Govindarajan S, Arakawa K, Yu MC. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer 2004;101:1009-1017.
9. Adami HO, Chow WH, Nyrén O, Berne C, Linet MS, Ekbom A, et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996;88:1472-1477.
10. Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Hepatology 2006;43:1295-1302.
11. Kessler II. Cancer mortality among diabetics. J Natl Cancer Inst 1970;44:673-686.
12. Lu SN, Lin TM, Chen CJ, Chen JS, Liaw YF, Chang WY, et al. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 1988;62:2051-2055.
13. Cimino L, Oriani G, DArienzo A, Manguso F, Loguercio C, Ascione A, et al. Interactions between metabolic disorders (diabetes, gallstones, and dyslipidaemia) and the progression of chronic hepatitis C virus infection to cirrhosis and hepatocellular carcinoma. A cross-sectional multicentre survey. Dig Liver Dis 2001;33:240-246.
14. Torisu Y, Ikeda K, Kobayashi M, Hosaka T, Sezaki H, Akuta N, et al. Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report. Hepatol Res 2007;37:517-523.
15. Di Costanzo GG, De Luca M, Tritto G, Lampasi F, Addario L, Lanza AG, et al. Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis. Eur J Gastroenterol Hepatol 2008;20:674-679.
16. Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 2008;47:1856-1862.
17. Huo TI, Wu JC, Lui WY, Huang YH, Lee PC, Chiang JH, et al. Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment. Am J Gastroenterol 2004;99:1479-1487.
18. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090-1101.
19. Huo TI, Lui WY, Huang YH, Chau GY, Wu JC, Lee PC, et al. Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study. Am J Gastroenterol 2003;98: 2293-2298.
20. Gao C, Zhao HC, Li JT, Yao SK. Diabetes mellitus and hepatocellular carcinoma: comparison of Chinese patients with and without HBV-related cirrhosis. World J Gastroenterol 2010;16:4467-4475.
21. El-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol 2001;96: 2462-2467.
22. Yu L, Sloane DA, Guo C, Howell CD. Risk factors for primary hepatocellular carcinoma in black and white Americans in 2000. Clin Gastroenterol Hepatol 2006;4:355-360.
23. Toyoda H, Kumada T, Nakano S, Takeda I, Sugiyama K, Kiriyama S, et al. Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma. Cancer 2001;91:957-963.
24. Poon RT, Fan ST, Wong J. Does diabetes mellitus infuence the perioperative outcome or long term prognosis after resection of hepatocellular carcinoma? Am J Gastroenterol 2002;97:1480-1488.
25. Tung HD, Wang JH, Tseng PL, Hung CH, Kee KM, Chen CH, et al. Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies. Am J Gastroenterol 2010;105:624-631.
26. Kawaguchi T, Yoshida T, Harada M, Hisamoto T, Nagao Y, Ide T, et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004;165:1499-1508.
27. Lee MS, Hsu CC, Wahlqvist ML, Tsai HN, Chang YH, Huang YC. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. BMC Cancer 2011;11:20.
28. Li D, Yeung SC, Hassan MM, Konopleva M, Abbruzzese JL. Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 2009;137:482-488.
29. Yang YX, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004;127:1044-1050.
30. Kawaguchi T, Izumi N, Charlton MR, Sata M. Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology 2011;54:1063-1070.
31. Kawaguchi T, Taniguchi E, Morita Y, Shirachi M, Tateishi I, Nagata E, et al. Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection. Liver Int 2010;30:479-486.
32. Tarantino G, Colicchio P, Conca P, Finelli C, Di Minno MN, Tarantino M, et al. Young adult obese subjects with and without insulin resistance: what is the role of chronic infammation and how to weigh it non-invasively? J Infamm (Lond) 2009;6:6.
33. Tarantino G, Conca P, Pasanisi F, Ariello M, Mastrolia M, Arena A, et al. Could infammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol 2009;21:504-511.